Skip to main content
Clinical Trials/JPRN-UMIN000049202
JPRN-UMIN000049202
Not yet recruiting
Phase 3

The efficacy of respiratory rehabilitation for COPD-related sarcopenia: a randomized controlled trial - Respiratory rehabilitation for COPD-related sarcopenia

ippon Sport Science University0 sites160 target enrollmentOctober 13, 2022

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
ippon Sport Science University
Enrollment
160
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 13, 2022
End Date
March 31, 2025
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ippon Sport Science University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. history of respiratory rehabilitation within one year. 2\. history of acute exacerbation within one month. 3\. patients using oxygen therapy. 4\. patients receiving chemotherapy. 5\. Severe diabetes mellitus (retinopathy, fundus hemorrhage, during dialysis, the complication of peripheral neuropathy) 6\. Severe heart disease (acute myocardial infarction, pacemaker wearer, unstable angina, uncontrolled heart failure, advanced obstructive hypertrophic cardiomyopathy, acute embolism, acute infectious diseases (pericarditis, myocarditis)

Outcomes

Primary Outcomes

Not specified

Similar Trials